French Pharma Firm Ordered to Pay Millions Over Deadly Diabetes Drug
PARIS — A French appeals court on Wednesday ordered pharmaceutical firm Servier to pay more than $460 million in damages over a scandal involving a diabetes drug linked to hundreds of deaths. The health scandal came to light in 2007 when a doctor raised the alert on heart risks linked to Mediator, a drug destined for overweight people with diabetes but that was also widely prescribed to others as an appetite-suppressant. The drug, which may have caused up to 1,800 deaths, was later banned in France where millions of people took it. It is also banned in the United States, Spain and Italy. In the latest court ruling in more than a decade of legal proceedings, the Paris appeals court upheld verdicts of "aggravated fraud" and "involuntary manslaughter and injuries." It…